Страна 1 од 75 резултати
BACKGROUND OF THE INVENTION
An estimated 21 million adults in the United States alone live with osteoarthritis, one of the most common types of arthritis. Osteoarthritis, also called degenerative joint disease, is caused by the breakdown of cartilage, the connective tissue that cushions the ends of
BACKGROUND OF THE INVENTION
An estimated 21 million adults in the United States alone live with osteoarthritis, one of the most common types of arthritis. Osteoarthritis, also called degenerative joint disease, is caused by the breakdown of cartilage, the connective tissue that cushions the ends of
BACKGROUND OF THE INVENTION
Field of the Invention
The invention relates to a method of reducing inflammation in animals. More particularly, the invention relates to the combination of egg product and glucosamine to produce a synergistic effect in reducing inflammation, and particularly arthritis,
The invention is generally related to the treatment of inflammatory conditions. More specifically, the invention is related to compositions containing inhibitors of mast cell activation and secretion designed to be used as dietary supplement in the treatment of inflammatory conditions.
There have
The present invention relates to galactosylated pro-drugs of non-steroidal anti-inflammatories with free acid function and the process of synthesis thereof, which enables minimization of the gastrointestinal toxicity of the starting anti-inflammatory by means of esterification of its carboxylic
BACKGROUND OF THE INVENTION
The invention is generally related to the treatment of inflammatory conditions. More specifically, the invention is related to compositions containing inhibitors of mast cell activation and secretion such as a proteoglyean that are designed to be used as dietary
BACKGROUND OF THE INVENTION
The invention is generally related to the treatment of inflammatory conditions. More specifically, the invention is related to compositions containing inhibitors of mast cell activation and secretion such as a proteoglycan that are designed to be used as dietary
BACKGROUND OF THE INVENTION
The invention is generally related to the treatment of inflammatory conditions. More specifically, the invention is related to compositions containing inhibitors of mast cell activation and secretion such as a proteoglycan that are designed to be used as dietary
BACKGROUND OF THE INVENTION
The invention is generally related to the treatment of inflammatory conditions. More specifically, the invention is related to compositions containing inhibitors of mast cell activation and secretion such as a proteoglycan that are designed to be used as dietary
CROSS-REFERENCE TO RELATED APPLICATION
This application is a National Phase Patent Application of International Application Number PCT/CN02/00118, filed on Feb. 28, 2002, which claims priority of Chinese Patent Application Number 01104884.0, filed on Feb. 28, 2001.
TECHNICAL FIELD
The present
BACKGROUND OF THE INVENTION
The present invention relates to therapeutic compositions and methods of treatment for conditions having an inflammatory component, and more specifically bone, joint or connective tissue inflammation. Examples of such conditions include arthritis, including osteoarthritis
BACKGROUND
Inflammatory diseases such as psoriasis, dermatitis, acne, rosacea, photo-dermal ageing, and numerous diseases linked to RAGE-mediated signaling plague people worldwide. To put these diseases into perspective, the National Psoriasis Foundation reports that psoriasis alone afflicts 2-3% of
BACKGROUND OF THE INVENTION
1. Field of the Invention
The present invention relates to compositions for the protection, treatment, repair and reduction of inflammation of connective tissue in humans and animals and, in particular, to compositions capable of promoting anti-inflammation,
This application is a 371 of PCT/EP2005/006804, filed Jun. 23, 2005; the disclosure of which is incorporated herein by reference.
TECHNICAL FIELD OF THE INVENTION
This invention relates to the use of an organic glucosamine salt for the treatment or prophylaxis of arthrosis, of the inflammation
BACKGROUND OF THE INVENTION
The present invention relates generally to methods of treatment and products for treating disorders. More specifically, the present invention relates to methods and compositions for preventing, treating or providing relief from inflammation of the joints, osteoarthritis,